Łukasz Szeleszczuk

74PUBLICATIONS
99CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)GlycoconjugatesNanomedicineArtificial life and complex adaptive systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (74)

|Sep 26, 2026
Rational Design of Putative Dual-Target Opioid-Dopaminergic Casomorphin-Ranatensin Hybrid Peptides: Computational Modeling and Preliminary Antiproliferative Evaluation.

|Sep 26, 2026
Methotrexate-Cyclodextrin Systems: Molecular Recognition, Formulation Design, and Translational Perspectives.

|Sep 26, 2026
Cyclodextrin Interactions with Water-Soluble Vitamins: Biological Relevance, Stability, Delivery, and Translational Implications-A Critical Review.

|Sep 15, 2026
The Translational Paradox of Cancer Nanomedicine: Biological, Pharmacokinetic, and Manufacturing Barriers to Clinical Success.

|Sep 15, 2026
Integrating Artificial Intelligence with Emerging Pharmaceutical Technologies: Current Progress, Clinical Translation, and Future Challenges.

|Aug 27, 2026
Evaluating the Incremental Value of Three-Dimensional Conformer Descriptors for Blood-Brain Barrier Permeability Prediction Using the B3DB Benchmark Dataset.

Pageof 13

Frequent Collaborators

13 joint publications

Marcin Gackowski

10 joint publications

Dariusz Maciej Pisklak

8 joint publications

Katarzyna Mądra-Gackowska

7 joint publications

Monika Zielińska-Pisklak